InvestorsHub Logo
Followers 62
Posts 2098
Boards Moderated 0
Alias Born 05/09/2020

Re: None

Saturday, 07/11/2020 6:42:05 PM

Saturday, July 11, 2020 6:42:05 PM

Post# of 233119
Another reason that leronlimab needs to get out there:

https://elemental.medium.com/official-covid-19-statistics-are-missing-something-critical-155e1e153a2f

The "morbidity" factor is affecting a significant number of people who were considered in the mild to moderate group. It's becoming more and more evident that COVID-19 isn't going to go away in a flash.

A close friend of mine suspects that he came down with it in February - before the major COVID-19 hit here in the US. He thought it was just a flu. He pursued his doctor and health care provider for COVID-19 testing and they said that since his symptoms no longer persisted he wasn't eligible for testing. A couple of weeks ago he suffered a stroke that has significantly affected him.

This is something Dr. BP has noted in his interviews and TEDx presentation. There needs to be MORE follow up treatments or we are going to have MILLIONS of walking wounded dragging our healthcare system down for years at this rate.

I hate to suggest it, but CytoDyn needs to start more leronlimab clinical trials for post-COVID treatment.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News